Assignee
CONVERGENCE PHARMACEUTICALS
GB12 patents
Top patents by PatentIndex Score
US7855218B2Dec 21, 2010
Compounds
CONVERGENCE PHARMACEUTICALS13 citations83
US9376445B2Jun 28, 2016
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS4 citations81
US9309254B2Apr 12, 2016
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS4 citations81
US10485801B2Nov 26, 2019
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS1 citations70
US10010551B2Jul 3, 2018
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS2 citations70
US9737536B2Aug 22, 2017
Pyrimidinyl-diazospiro compounds
CONVERGENCE PHARMACEUTICALS3 citations70
US10421716B2Sep 24, 2019
Process for preparing alpha-carboxamide pyrrolidine derivatives
CONVERGENCE PHARMACEUTICALS1 citations53
US9303032B2Apr 5, 2016
2-(pyridin-2YL)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulator
CONVERGENCE PHARMACEUTICALS0 citations49
US10231950B2Mar 19, 2019
Erythromelalgia treatment
CONVERGENCE PHARMACEUTICALS1 citations47
US9750719B2Sep 5, 2017
Tetrazole compounds as calcium channel blockers
CONVERGENCE PHARMACEUTICALS0 citations46
US9376436B2Jun 28, 2016
2-(pyridin-2yl)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulators
CONVERGENCE PHARMACEUTICALS1 citations46
US10493059B2Dec 3, 2019
Paroxysmal extreme pain disorder treatment
CONVERGENCE PHARMACEUTICALS0 citations36